APA (7th ed.) Citation

SE, H., ES, D., MR, N., MR, P., SS, A., E, M., . . . MP, B. (2024). Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation, 149(8), 635. https://doi.org/10.1161/CIRCULATIONAHA.123.065330

Chicago Style (17th ed.) Citation

SE, Hogan, et al. "Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD." Circulation 149, no. 8 (2024): 635. https://doi.org/10.1161/CIRCULATIONAHA.123.065330.

MLA (9th ed.) Citation

SE, Hogan, et al. "Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD." Circulation, vol. 149, no. 8, 2024, p. 635, https://doi.org/10.1161/CIRCULATIONAHA.123.065330.